Estimaciones de analistas de Wall Street para OraSure Technologies, Inc. (OSUR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-04 | $-0.23 | ||
| 2026-08-05 | $0.09 | $-0.27 | +133.3% |
| 2026-05-06 | $-0.32 | $-0.23 | -39.1% |
| 2026-02-25 | $-0.27 | $-0.17 | -58.8% |
| 2025-11-05 | $-0.19 | $-0.16 | -18.8% |
| 2025-08-05 | $-0.26 | $-0.19 | -36.8% |
| 2025-05-07 | $-0.18 | $-0.15 | -20.0% |
| 2025-02-25 | $-0.14 | $-0.05 | -180.0% |
Ratios de valoración
| Precio / Valor contable | 0.73 |
| EV / EBITDA | -2.07 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $122.8M | $167.1M | $181.7M | $154.6M | $171.7M | $233.7M | $387.5M | $405.5M | $185.8M | $115.0M |
| Coste de Ventas | $40.2M | $68.1M | $68.1M | $60.0M | $69.9M | $116.1M | $239.0M | $226.1M | $109.6M | $66.8M |
| Beneficio Bruto | $82.6M | $99.0M | $113.6M | $94.6M | $101.9M | $117.6M | $148.4M | $179.4M | $76.2M | $48.2M |
| I+D | $9.8M | $13.4M | $16.2M | $19.6M | $31.0M | $34.2M | $36.2M | $33.2M | $24.4M | $42.5M |
| Generales y Administrativos | $58.0M | $57.9M | $58.1M | $66.0M | $76.7M | $95.1M | $117.4M | $92.2M | $72.4M | $73.8M |
| Gastos Operativos | $67.8M | $71.2M | $74.3M | $85.6M | $107.8M | $129.2M | $153.7M | $125.3M | $96.8M | $116.3M |
| Beneficio Operativo | $14.9M | $27.7M | $39.3M | $9.0M | -$5.9M | -$11.6M | -$5.2M | $54.1M | -$20.6M | -$68.1M |
| EBITDA | $20.6M | $34.1M | $45.7M | $16.3M | $3.5M | $2.4M | -$1.7M | $76.2M | -$6.8M | -$57.0M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | $20.3M | $41.0M | $31.7M | $21.3M | -$3.5M | -$9.3M | -$15.7M | $56.3M | -$17.7M | -$66.9M |
| Impuestos | $603000 | $10.1M | $11.3M | $4.7M | $11.4M | $13.7M | $1.5M | $2.6M | $1.8M | $1.8M |
| Beneficio Neto | $19.7M | $30.9M | $20.4M | $16.7M | -$14.9M | -$23.0M | -$17.1M | $53.7M | -$19.5M | -$68.7M |
| BPA | $0.35 | $0.52 | $0.33 | $0.27 | $-0.22 | $-0.32 | $-0.25 | $0.73 | $-0.26 | $-0.94 |
| BPA Diluido | $0.35 | $0.51 | $0.33 | $0.27 | $-0.22 | $-0.32 | $-0.25 | $0.72 | $-0.26 | $-0.94 |
| Acciones en Circulación (Diluidas) | $56.5M | $61.0M | $62.5M | $62.2M | $67.5M | $72.0M | $72.5M | $74.4M | $74.4M | $73.5M |
Precio
| Precio | $3.49 |
| Capitalización | $240M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CATX · GNFT · NAUT · NTHI · NYXH · PRE · PROF
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de OSUR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones